Search Within

Parastoo Bahrami Dahi

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Meeting Abstract (36)
  2. Journal Article (24)
Groups
  1. Bone Marrow Transplant (60)
  2. CTCR Scholars (60)
  3. Center for Hematologic Malignancies (60)
  4. Department of Medicine (60)
  5. Hematologic Malignancies, Division of (60)
  6. MSK Grad Students (60)

More Groups

People
  1. Gunjan Shah (49)
  2. Michael Scordo (49)
  3. Miguel-Angel Perales (45)
  4. Sean Devlin (42)
  5. Sergio Giralt (39)
  6. Richard Lin (36)

More People

Years
  1. 2025 (2)
  2. 2024 (8)
  3. 2023 (21)
  4. 2022 (7)
  5. 2021 (6)
  6. 2020 (7)

More Years

Publications
  1. Blood (22)
  2. Biology of Blood and Marrow Transplantation (6)
  3. Blood Advances (4)
  4. Transplantation and Cellular Therapy (4)
  5. Bone Marrow Transplantation (3)
  6. Leukemia and Lymphoma (3)

More Publications

Publishers
  1. American Society of Hematology (26)
  2. Elsevier Inc. (14)
  3. Nature Publishing Group (5)
  4. Taylor & Francis Group (3)
  5. John Wiley & Sons (2)
  6. Oxford University Press (2)

More Publishers

Results (60)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma
    Journal Article

    Alarcon Tomas, A.; Fein, J. A.; Fried, S.; Flynn, J. R.; Devlin, S. M.; Fingrut, W. B.; Anagnostou, T.; Alperovich, A.; Shah, N.; Fraint, E.; more...
    Leukemia (2023)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic cell transplantation in patients with relapsed or refractory acute leukemia
    Meeting Abstract

    Elias, S.; Walji, M.; Brown, S.; Devlin, S. M.; Papadopoulos, E. B.; Jakubowski, A. A.; Ponce, D. M.; Young, J. W.; Giralt, S. A.; Perales, M. A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Stem cell autograft minimal residual disease negativity improves outcomes after autotransplant for multiple myeloma
    Meeting Abstract

    Nishimura, N.; Brown, S.; Devlin, S. M.; Dahi, P. B.; Landau, H.; Lahoud, O. B.; Scordo, M.; Shah, G. L.; Hassoun, H.; Hultcrantz, M.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Vitamin D insufficiency and clinical outcomes with chimeric antigen receptor T-cell therapy in large B-cell lymphoma
    Journal Article

    Nath, K.; Tomas, A. A.; Flynn, J.; Fein, J. A.; Alperovich, A.; Anagnostou, T.; Batlevi, C. L.; Dahi, P. B.; Fingrut, W. B.; Giralt, S. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Patterns of relapse and risk reduction following tumor debulking by bridging radiotherapy prior to chimeric antigen receptor T cell therapy in non-Hodgkin lymphoma
    Meeting Abstract

    Hubbeling, H. G.; Silverman, E. A.; Michaud, L.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Alarcon Tomas, A.; Shouval, R.; Palomba, M. L.; Batlevi, C. L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Vitamin D deficiency is associated with inferior clinical outcomes in patients with large B-cell lymphoma receiving anti-CD19 CAR T-cell therapy
    Meeting Abstract

    Nath, K.; Alarcon Tomas, A.; Flynn, J.; Fein, J. A.; Alperovich, A.; Anagnostou, T.; Batlevi, C. W.; Dahi, P. B.; Fingrut, W.; Giralt, S. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Population pharmacokinetics of melphalan in a large cohort of autologous and allogeneic hematopoietic cell transplantation recipients: Towards individualized dosing regimens
    Journal Article

    Shah, G. L.; Boelens, J. J.; Carlow, D.; Lin, A.; Schofield, R.; Cruz Sitner, N.; Alperovich, A.; Ruiz, J.; Proli, A.; Dahi, P.; more...
    Clinical Pharmacokinetics (2022)

    Fulltext@MSK | Save
  • Impact of TP53 genomic alterations in large B-cell lymphoma treated with CD19-chimeric antigen receptor T-cell therapy
    Journal Article

    Shouval, R.; Alarcon Tomas, A.; Fein, J. A.; Flynn, J. R.; Markovits, E.; Mayer, S.; Afuye, A. O.; Alperovich, A.; Anagnostou, T.; Besser, M. J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Novel agents may be preferable to chemotherapy for large B-cell lymphoma progressing after CD19-CAR-T: A multicenter observational study
    Meeting Abstract

    Tomas, A. A.; Fein, J. A.; Fried, S.; Fingrut, W.; Anagnostou, T.; Alperovich, A.; Shah, N.; Fraint, E.; Lin, R. J.; Scordo, M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Daratumumab versus lenalidomide maintenance therapy for multiple myeloma: A randomized pilot study comparing patient-reported health related quality of life measures
    Meeting Abstract

    Shah, U. A.; Malik, M.; Werner, K.; Burge, M.; Devlin, S. M.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Tan, C.; more...
    Blood (2021)

    Fulltext@MSK | Save